Larvol Delta - Evidence-for-alpha-nicotinic-receptor-activation-during-the-cough-suppressing-effects-induced-by-nicotine-and-identification-of-ATA101-as-a-potential-novel-therapy-for-the-treatment-of-chronic-cough

bradanicline (ATA-101) - CODA Biotherap

AZD1466 - AstraZeneca, Catalyst Biosci

http://www.ncbi.nlm.nih.gov/pubmed/34782407

Nov 18, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next